Tdap vaccine 7 yrs/> im
Products billed under this code include Adacel, Boostrix.
Payment limit per 0.5 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Adacel, Boostrix.
Payment limit per 0.5 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Adacel | Sanofi Pasteur Inc. | 49281-0400-10 | 10 | $400.72 |
| Adacel | Sanofi Pasteur Inc. | 49281-0400-20 | 5 | $200.36 |
| Boostrix | A-S Medication Solutions | 50090-1377-00 | 10 | $400.72 |
| Boostrix | A-S Medication Solutions | 50090-1831-00 | 10 | $400.72 |
| Boostrix | GlaxoSmithKline LLC | 58160-0842-11 | 10 | $400.72 |
| Boostrix | GlaxoSmithKline LLC | 58160-0842-52 | 10 | $400.72 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $40.072 | −$0.218 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted September 17, 2026 |
| 3Q26 | $40.29 | +$0.811 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted September 15, 2026 |
| 2Q26 | $39.479 | −$0.211 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted September 15, 2026 |
| 1Q26 | $39.69 | −$0.123 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted September 15, 2026 |
| 4Q25 | $39.813 | +$0.104 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted September 8, 2026 |
| 3Q25 | $39.709 | +$0.639 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted March 10, 2026 |
| 2Q25 | $39.07 | +$0.442 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted March 10, 2026 |
| 1Q25 | $38.628 | +$0.108 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted December 19, 2025 |
| 4Q24 | $38.52 | +$0.133 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted June 11, 2025 |
| 3Q24 | $38.387 | −$0.699 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted June 11, 2025 |
| 2Q24 | $39.086 | +$0.781 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted March 11, 2025 |
| 1Q24 | $38.305 | −$0.366 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted December 19, 2024 |
| 4Q23 | $38.671 | −$0.074 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted October 10, 2024 |
| 3Q23 | $38.745 | +$1.116 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted June 5, 2024 |
| 2Q23 | $37.629 | +$0.131 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted February 23, 2024 |
| 1Q23 | $37.498 | −$0.779 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted December 6, 2023 |
| 4Q22 | $38.277 | +$1.517 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted June 22, 2023 |
| 3Q22 | $36.76 | +$1.125 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted June 9, 2023 |
| 2Q22 | $35.635 | −$0.527 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted December 14, 2022 |
| 1Q22 | $36.162 | +$0.367 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted June 8, 2022 |
| 4Q21 | $35.795 | +$0.141 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted June 2, 2022 |
| 3Q21 | $35.654 | +$2.438 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted June 2, 2022 |
| 2Q21 | $33.216 | −$0.844 | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted March 1, 2022 |
| 1Q21 | $34.06 | – | 0.5 ML | Tdap vaccine 7 yrs/> im | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.